Rosenberg ES - Search Results

1

Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection.

Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, Brockman MA, Allgaier RL, Waring MT, Koibuchi T, Johnston MN, Cohen D, Allen TM, Rosenberg ES, Walker BD, Altfeld M. Lichterfeld M, et al. Among authors: rosenberg es. J Virol. 2007 Apr;81(8):4199-214. doi: 10.1128/JVI.01388-06. Epub 2007 Feb 7. J Virol. 2007. PMID: 17287271 Free PMC article.

2

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. Rosenberg ES, et al. Science. 1997 Nov 21;278(5342):1447-50. doi: 10.1126/science.278.5342.1447. Science. 1997. PMID: 9367954

3

HIV type 1-specific helper T cells: a critical host defense.

Rosenberg ES, Walker BD. Rosenberg ES, et al. AIDS Res Hum Retroviruses. 1998 Jun;14 Suppl 2:S143-7. AIDS Res Hum Retroviruses. 1998. PMID: 9672231 Review. No abstract available.

4

Immune control of HIV-1 replication.

Walker BD, Rosenberg ES, Hay CM, Basgoz N, Yang OO. Walker BD, et al. Among authors: rosenberg es. Adv Exp Med Biol. 1998;452:159-67. doi: 10.1007/978-1-4615-5355-7_17. Adv Exp Med Biol. 1998. PMID: 9889969 Review. No abstract available.

5

Acute HIV infection among patients tested for mononucleosis.

Rosenberg ES, Caliendo AM, Walker BD. Rosenberg ES, et al. N Engl J Med. 1999 Mar 25;340(12):969. doi: 10.1056/nejm199903253401217. N Engl J Med. 1999. PMID: 10094651 No abstract available.

6

Characterization of HIV-1-specific T-helper cells in acute and chronic infection.

Rosenberg ES, LaRosa L, Flynn T, Robbins G, Walker BD. Rosenberg ES, et al. Immunol Lett. 1999 Mar;66(1-3):89-93. doi: 10.1016/s0165-2478(98)00165-5. Immunol Lett. 1999. PMID: 10203039

7

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.

Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, Jones NG, Shea AK, Trocha AK, Walker BD. Kalams SA, et al. Among authors: rosenberg es. J Virol. 1999 Aug;73(8):6715-20. doi: 10.1128/JVI.73.8.6715-6720.1999. J Virol. 1999. PMID: 10400769 Free PMC article.

8

Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters.

Lori F, Rosenberg E, Lieberman J, Foli A, Maserati R, Seminari E, Alberici F, Walker B, Lisziewicz J. Lori F, et al. AIDS Res Hum Retroviruses. 1999 Oct 10;15(15):1333-8. doi: 10.1089/088922299310034. AIDS Res Hum Retroviruses. 1999. PMID: 10515148

9

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir.

Lori F, Jessen H, Lieberman J, Finzi D, Rosenberg E, Tinelli C, Walker B, Siliciano RF, Lisziewicz J. Lori F, et al. J Infect Dis. 1999 Dec;180(6):1827-32. doi: 10.1086/315113. J Infect Dis. 1999. PMID: 10558937 Clinical Trial.

10

Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

Goulder PJ, Brander C, Annamalai K, Mngqundaniso N, Govender U, Tang Y, He S, Hartman KE, O'Callaghan CA, Ogg GS, Altfeld MA, Rosenberg ES, Cao H, Kalams SA, Hammond M, Bunce M, Pelton SI, Burchett SA, McIntosh K, Coovadia HM, Walker BD. Goulder PJ, et al. Among authors: rosenberg es. J Virol. 2000 Jun;74(12):5679-90. doi: 10.1128/jvi.74.12.5679-5690.2000. J Virol. 2000. PMID: 10823876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page